Scientists already know that some drugs boost the growth of new neurons in the brain. Antidepressants, for example, trigger the birth of brain cells in an area involved in learning and memory, which might play a role in the drugs’ ability to fight depression. Now, companies are seeking compounds that are better at enhancing the brain’s ability to grow new cells. This could improve treatments for diseases like Alzheimer’s and Parkinson’s, as well as depression.
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
Data analytics reveal real business value
Sophisticated analytics tools mine insights from data, optimizing operational processes across the enterprise.
Driving companywide efficiencies with AI
Advanced AI and ML capabilities revolutionize how administrative and operations tasks are done.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.